Specifically, a meta-analysis of the ELIXA, LEADER, SUSTAIN-6, EXSCEL, REWIND and AMPLITUDE-O trials in type 2 diabetes estimated a 21% reduction in the risk of new-onset macroalbuminuria, eGFR decline, progression to ESKD or death attributable to kidney causes with GLP1-RAs compared with placebo [48]
BPC-157 Capsules: Benefits, Absorption, and Daily Use Oral BPC 157 is typically available in capsule form
Evidence summarized in a clinical review on nutraceutical management of concussion suggests curcumin may help mitigate secondary injury cascades that follow concussion (source)
J.SprostonJ
Important contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and pregnancy